FR2620706A1 - Process for solvent treatment of DNA in a heterogeneous phase - Google Patents

Process for solvent treatment of DNA in a heterogeneous phase Download PDF

Info

Publication number
FR2620706A1
FR2620706A1 FR8713010A FR8713010A FR2620706A1 FR 2620706 A1 FR2620706 A1 FR 2620706A1 FR 8713010 A FR8713010 A FR 8713010A FR 8713010 A FR8713010 A FR 8713010A FR 2620706 A1 FR2620706 A1 FR 2620706A1
Authority
FR
France
Prior art keywords
dna
solvent
support
treatment
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8713010A
Other languages
French (fr)
Inventor
Daniel Dupret
Martine Sauvageot
Veronique Harsany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Appligene SA Labo Biolog Molec
Original Assignee
Appligene SA Labo Biolog Molec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Appligene SA Labo Biolog Molec filed Critical Appligene SA Labo Biolog Molec
Priority to FR8713010A priority Critical patent/FR2620706A1/en
Priority to JP50786188A priority patent/JPH02501353A/en
Priority to PCT/FR1988/000461 priority patent/WO1989002436A1/en
Priority to EP19880908250 priority patent/EP0333813A1/en
Publication of FR2620706A1 publication Critical patent/FR2620706A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Saccharide Compounds (AREA)

Abstract

Process for solvent treatment of DNA previously attached in a noncovalent and reversible manner upon a support. The DNA is treated with at least one solvent in which it is insoluble, just like the support. This treatment enables the DNA molecule to undergo chemical or enzymatic modifications, or the DNA to be isolated. The process finds its application in the elution of DNA from agarose gels, the isolation of DNA of high purity and the chemical modification of DNA.

Description

La pressente invention a pour objet un procédé de traitement par solvants dtADN en phase hétérogéne.  The subject of the present invention is a method of treatment with dtDNA solvents in the heterogeneous phase.

On sait que 1'ADN est soluble presqu exclusivement dans l'eau, ce qui rend très difficile, voire impossible, cie lui faire subir des transformations chimiques faisant intervenir des réactions dans des solvants non miscibles à l'eau. It is known that DNA is soluble almost exclusively in water, which makes it very difficult, if not impossible, to subject it to chemical transformations involving reactions in solvents immiscible with water.

On connaît également les difficultés -rencontrées dans l'obtention d'ADN purifié, les procédés mis au point à ce jour faisant appel à une succession d'extractions en phases liquides qui présentent l'inconvénient d'être longues et délicates. We also know the difficulties encountered in obtaining purified DNA, the processes developed to date using a succession of extraction in liquid phases which have the drawback of being long and delicate.

Parmi ces procédés, l'un des plus récents consiste à fixer 1'ADN en -solution aqueuse sur les particules d'une poudre de verre au moyen d'un agent chaiotropique tel que l'iodure de sodium ou le perchlorate de potassium. Cette fixation se faisant sélectivement permet de séparer 1'ADN des protéines et de 1'ARN en solution qui l'accompagnent généralement, et conduit à l'obtention d'un produit de fixation de 1'ADN sur la poudre de verre, dont on sépare 1'ADN par une élution pratiquée au moyen d'une solution aqueuse. La solution d'ADN ainsi obtenue doit être ensuite soumise à une succession d'opérations de purification, qui consistent généralement en des traitements successifs à la RNase, à la protéinase K, au phénol et au chloroforme, tous opérés en phases liquides. Among these methods, one of the most recent consists in fixing the DNA in aqueous solution on the particles of a glass powder by means of a chaiotropic agent such as sodium iodide or potassium perchlorate. This binding takes place selectively to separate the DNA from the proteins and the RNA in solution which generally accompany it, and leads to the production of a DNA binding product on the glass powder, of which separates the DNA by an elution carried out using an aqueous solution. The DNA solution thus obtained must then be subjected to a succession of purification operations, which generally consist of successive treatments with RNase, proteinase K, phenol and chloroform, all operated in liquid phases.

I1 ressort de ce qui précéde que le traitement de 1'ADN se heurte à des difficultés non négligeables, dont la moindre n'est pas le nombre d'opérations successives mises en oeuvre, qui nuit à la rentabilité du traitement, empêchant en particulier la mise au point d'appareillages automatiques susceptibles de faciliter les manipulations et d'en accroître le rendement. It appears from the foregoing that the treatment of DNA faces significant difficulties, the least of which is not the number of successive operations implemented, which affects the profitability of the treatment, preventing in particular the development of automatic devices capable of facilitating handling and increasing performance.

La présente invention a pour but de remédier à ces divers inconvénients en proposant un procédé de traitement de 1'ADN qui rend aisée sa manipulation, que celle-ci vise à la modification chimique ou enzymatique de sa molécule ou à l'obtention d'ADN purifié. The object of the present invention is to remedy these various drawbacks by proposing a process for the treatment of DNA which makes its manipulation easy, whether this is aimed at the chemical or enzymatic modification of its molecule or in obtaining DNA. purified.

Le procédé selon l'invention consiste à traiter par au moins un solvant 1'ADN fixé de façon non covalente et réversible sur un support insoluble à la fois dans ledit solvant et dans 1 'eau.  The method according to the invention consists in treating, with at least one solvent, the DNA fixed noncovalently and reversibly on a support insoluble both in said solvent and in water.

Le solvant mis en oeuvre dans le procédé selon l'invention peut être n'importe quel solvant organique ou minéral présentant la particularité de ne pas solubiliser 1'ADN. I1 peut être additionné d'eau ou d'une solution aqueuse d'au moins un sel minéral pouvant renfermer également au moins un agent tampon,un agent chélatant et/ou un agent antioxydant. The solvent used in the process according to the invention can be any organic or inorganic solvent having the particularity of not dissolving the DNA. It can be added with water or an aqueous solution of at least one mineral salt which may also contain at least one buffering agent, a chelating agent and / or an antioxidant agent.

A titre d'exemple de solvants utilisables dans le procédé selon l'invention, on peut citer le chloroforme, l'éthanol, l'isopropanol, le butanol ou encore une solution aqueuse saturée de phénol. By way of example of solvents which can be used in the process according to the invention, mention may be made of chloroform, ethanol, isopropanol, butanol or else a saturated aqueous solution of phenol.

L'eau susceptible d'être ajoutée au solvant peut être additionnée par exemple d'une faible quantité de chlorure de sodium, d'EDTA ou de Tris HC1. The water capable of being added to the solvent can be added for example with a small amount of sodium chloride, EDTA or Tris HCl.

Le support utilisé pour fixer 1'ADN peut être n'importe quel support finement divisé susceptible de fixer 1'ADN de façon réversible et présentant la particularité de n'être soluble ni dans l'eau ni dans le solvant. The support used to fix the DNA may be any finely divided support capable of reversibly fixing the DNA and having the particularity of being soluble neither in water nor in the solvent.

A titre d'exemple de tels supports, on peut citer la poudre de verre, et de préférence celle obtenue par broyage de flacons de scintillation, les particules retenues étant celles sédimentant à moins de 0,25 cm/minute, de dimensions égales ou inférieures à 5 microns. As an example of such supports, mention may be made of glass powder, and preferably that obtained by grinding scintillation vials, the particles retained being those which sediment at less than 0.25 cm / minute, of equal or smaller dimensions. at 5 microns.

L'ADN est fixé sur le support insoluble dans les conditions imposées par la nature dudit support : ainsi, dans le cas où le support est de la poudre de verre, la fixation se fera au moyen d'un agent chaiotropique tel que l'iodure de sodium ou le perchlorate de potassium. The DNA is fixed on the insoluble support under the conditions imposed by the nature of said support: thus, in the case where the support is glass powder, the fixing will be done by means of a chaiotropic agent such as iodide sodium or potassium perchlorate.

Dans un but de simplification, le produit de fixation de 1'ADN sur le support sera désigné dans tout ce qui suit par "complexe ADN - support". For the purpose of simplification, the product for fixing the DNA on the support will be designated in the following text as "DNA-support complex".

Dans un premier mode de réalisation du procédé selon l'invention, le complexe ADN - support est soumis à un traitement par solvant en vue d'une modification chimique ou enzymatique de sa molécule au moyen d'un réactif convenable. In a first embodiment of the method according to the invention, the DNA-support complex is subjected to a treatment by solvent with a view to chemical or enzymatic modification of its molecule by means of a suitable reagent.

Dans ce cas, le traitement par solvant conduit à l'obtention d'une suspension, dans ledit solvant, du complexe ADNsupport. La suspension obtenue présente l'avantage de pouvoir être facilement mise en oeuvre dans des réactions chimiques ou enzymatiques visant à modifier la molécule d'ADN. In this case, the treatment with solvent leads to the production of a suspension, in said solvent, of the DNA support complex. The suspension obtained has the advantage of being able to be easily used in chemical or enzymatic reactions aiming to modify the DNA molecule.

Dans un second mode de réalisation du procédé selon l'invention, le complexe ADN - support est soumis à un traitement par solvant en vue de l'obtention d'ADN purifié.  In a second embodiment of the method according to the invention, the DNA-support complex is subjected to a solvent treatment with a view to obtaining purified DNA.

Dans ce cas, le traitement par solvant vise essentiellement à séparer de l'ADN les molécules contaminantes qui s'y trouvent fixées. Ces molécules contaminantes peuvent être entre autres des protéines, de l'agarose, des corps gras ou des agents fluorescents tels que le bromure d'éthidium, utilisés pour le marquage des molécules d'ADN. In this case, the solvent treatment essentially aims at separating from the DNA the contaminating molecules which are attached to it. These contaminating molecules can be among others proteins, agarose, fatty substances or fluorescent agents such as ethidium bromide, used for the labeling of DNA molecules.

Le choix du solvant est dans ce cas fonction de l'origine de l'ADN à purifier : ainsi dans le cas où l'ADN est contaminé en majeure partie par des protéines, on utilisera avantageusement du phénol saturé d'eau, tandis que dans le cas où le contaminant est essentiellement constitué de c-orps gras, le solvant sera de préférence du chloroforme. The choice of solvent in this case depends on the origin of the DNA to be purified: thus in the case where the DNA is contaminated for the most part with proteins, phenol saturated with water will advantageously be used, while in if the contaminant consists essentially of fatty c-orps, the solvent will preferably be chloroform.

Dans ce second mode de réalisation du procédé selon l'invention, le traitement par solvant du complexe ADN - support est suivi d'une élution de l'ADN du support, opérée au moyen d'eau éventuellement additionnée d'au moins un sel minéral, au moins un agent tampon, au moins un agent chélatant et/ou au moins un agent antioxydant. In this second embodiment of the method according to the invention, the solvent treatment of the DNA-support complex is followed by an elution of the DNA from the support, carried out by means of water optionally added with at least one mineral salt , at least one buffering agent, at least one chelating agent and / or at least one antioxidant agent.

L'ADN ainsi obtenu est d'une grande pureté, et peut être conservé dans la solution d'élution. The DNA thus obtained is of high purity, and can be stored in the elution solution.

Le procédé selon l'invention se trouve illustré par l'exemple non limitatif qui suit, et qui se rapporte à son second mode de réalisation. The method according to the invention is illustrated by the nonlimiting example which follows, and which relates to its second embodiment.

EXEMPLE
Cet exemple décrit l'obtention d'ADN plasmidique de la bactérie "ESCHERICHIA COLI".
EXAMPLE
This example describes the obtaining of plasmid DNA from the bacterium "ESCHERICHIA COLI".

1) On prend 1,5 ml de culture de la bactérie que l'on centrifuge et on reprend le culot dans 100 ul de TGE (Tris HCl 25 mM pH 7,5 ; EDTA l0mM ; Glucose 50 mM). Toutes les étapes ultérieures sont réalisées à 4 C.  1) 1.5 ml of the culture of the bacteria are taken which is centrifuged and the pellet is taken up in 100 μl of TGE (25 mM Tris HCl pH 7.5; 10 mM EDTA; 50 mM Glucose). All subsequent steps are carried out at 4 C.

2) On rajoute 200 > il de solution NaOH 0,2 M SDS 1% et on mélange. 2) 200 μl of 0.2 M 1% SDS NaOH solution are added and mixed.

3) On rajoute 150 ul d'acétate de potassium 5 M pH 5, on mélange et on laisse agir 5 minutes. 3) 150 μl of 5 M potassium acetate, pH 5, are added, mixed and left to act for 5 minutes.

4) On centrifuge pendant 2 à 5 minutes (centrifugeuse type microfuge), et on récupère 400 yl de surnageant. 4) Centrifuge for 2 to 5 minutes (microfuge type centrifuge), and 400 μl of supernatant are recovered.

5) On rajoute 800 ,ul de solution aqueuse de NaI 8 M et environ 2,5 mg de poudre de verre. On mélange 5 minutes. 5) 800 μl of 8 M aqueous NaI solution and approximately 2.5 mg of glass powder are added. Mix for 5 minutes.

6) On centrifuge pendant 1 à 5 minutes et on élimine le surnageant.  6) Centrifuge for 1 to 5 minutes and remove the supernatant.

7) On reprend le culot dans 400 ul de phénol saturé en eau et on agite pendant 5 minutes. 7) The pellet is taken up in 400 μl of water-saturated phenol and the mixture is stirred for 5 minutes.

8) On centrifuge pendant 1 à 5 minutes et on élimine le surnageant (l'étape 7 peut être réalisée deux fois si nécessaire). 8) Centrifuge for 1 to 5 minutes and remove the supernatant (step 7 can be carried out twice if necessary).

9) On reprend le culot dans 400 ul de chloroforme et on mélange pendant 5 minutes. 9) The pellet is taken up in 400 μl of chloroform and mixed for 5 minutes.

l0-) On centrifuge pendant 1 à 5 minutes et on élimine le surnageant. 10-) Centrifuge for 1 to 5 minutes and remove the supernatant.

11) On reprend le culot dans 1 ml de solution de lavage à 50% d'éthanol, TE, NaCl 0,3M (TE = Tris HCl 10 m M - pH 7,5 ; EDTA 1 mM). On mélange pendant 5 minutes. 11) The pellet is taken up in 1 ml of washing solution at 50% ethanol, TE, 0.3M NaCl (TE = 10 m M Tris HCl - pH 7.5; 1 mM EDTA). Mix for 5 minutes.

12) On centrifuge pendant 1 à 5 minutes et on récupère le surnageant. 12) Centrifuge for 1 to 5 minutes and recover the supernatant.

13) On reprend le culot dans 50 à 100 )il de TE et cn mélange 5 minutes. 13) The pellet is taken up in 50 to 100) of TE and mixed for 5 minutes.

14) On centrifuge pendant 5 minutes et on récupère le surnageant. 14) Centrifuge for 5 minutes and recover the supernatant.

L'ADN plasmidique obtenu est extrêmement pur, les étapes de traitement à la RNase, à la protéinase K, au phénol, au chloroforme ne sont plus nécessaires. The plasmid DNA obtained is extremely pure, the steps of treatment with RNase, with proteinase K, with phenol, with chloroform are no longer necessary.

L'PDN ainsi préparé a été testé dans différentes réactions de biologie moléculaire et les résultats obtenus ont confirmé sa haute pureté. The PDN thus prepared was tested in various molecular biology reactions and the results obtained confirmed its high purity.

Le procédé selon l'invention, ainsi qu'il a déjà té dit, offre l'avantage de permettre le traitement chimique de l'ADN sans recourir à une multiplicité d'opérations délicates et de faible rendement. The method according to the invention, as has already been said, offers the advantage of allowing the chemical treatment of DNA without resorting to a multiplicity of delicate operations and of low yield.

Il rend également possible l'obtention d'ADN de grande pureté par une suite d'opérations simples, facilement automatisables. It also makes it possible to obtain DNA of high purity by a series of simple operations, easily automated.

Il trouve ainsi une application particulièrement intéressante dans l'élution d'ADN de gels d'agarose, l'isolement d'ADN de diverses origines et la modification chimique de molécules d'ADN.  It thus finds a particularly interesting application in the elution of DNA from agarose gels, the isolation of DNA from various origins and the chemical modification of DNA molecules.

Claims (8)

REVENDICATIONS l) Procédé de traitement de l'ADN, caractérisé en ce que l'on traite l'ADN, préalablement fixé de façon non covalente et réversible sur un support, par au moins un solvant dans lequel l'ADN et le support sont insolubles. l) DNA treatment process, characterized in that the DNA, previously fixed in a non-covalent and reversible manner on a support, is treated with at least one solvent in which the DNA and the support are insoluble. 2) Procédé selon la revendication 1, caractérisé en ce que le support est de la poudre de verre. 2) Method according to claim 1, characterized in that the support is glass powder. 3) Procédé selon la revendication 1, caractérisé en ce que le solvant-est un solvant organique ou minéral, ou un mélange des deux. 3) Method according to claim 1, characterized in that the solvent is an organic or inorganic solvent, or a mixture of the two. 4) Procédé selon la revendication 3, caractérisé en ce que le solvant est additionné d'eau. 4) Method according to claim 3, characterized in that the solvent is added with water. 5) Procédé selon la revendication 4, caractérisé en ce que 1 'eau ajoutée au solvant renferme au moins un composé choisi dans le groupe que-constituent les sels minéraux, les agents tampon, les agents chélatants et les agents antioxydants. 5) Process according to claim 4, characterized in that the water added to the solvent contains at least one compound chosen from the group consisting of mineral salts, buffering agents, chelating agents and antioxidant agents. 6) Procédé selon la revendication 3, caractérisé en ce que le solvant est choisi dans le groupe que constituent le chloroforme, l'éthanol, l'isopropanol, le butanol et le phénol en solution aqueuse. 6) Method according to claim 3, characterized in that the solvent is chosen from the group consisting of chloroform, ethanol, isopropanol, butanol and phenol in aqueous solution. 7) Procédé selon la revendication 1, appliqué à la modification chimique de la molécule d'ADN, caractérisé en ce que l'ADN fixé sur le support est soumis à une réaction chimique au sein dudit solvant. 7) Method according to claim 1, applied to the chemical modification of the DNA molecule, characterized in that the DNA fixed on the support is subjected to a chemical reaction within said solvent. 8) Procédé selon la revendication 1, appliqué à l'obtention d'ADN purifié, caractérisé en ce que, postérieurement au traitement par solvant, l'ADN est élué du support par de l'eau éventuellement additionnée d'au moins un composé choisi dans le groupe que constituent les sels minéraux, les agents tampon, les agents chélatants et les agents antioxydants.  8) Method according to claim 1, applied to obtaining purified DNA, characterized in that, after the solvent treatment, the DNA is eluted from the support by water optionally added with at least one chosen compound in the group of mineral salts, buffering agents, chelating agents and antioxidant agents.
FR8713010A 1987-09-17 1987-09-17 Process for solvent treatment of DNA in a heterogeneous phase Withdrawn FR2620706A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8713010A FR2620706A1 (en) 1987-09-17 1987-09-17 Process for solvent treatment of DNA in a heterogeneous phase
JP50786188A JPH02501353A (en) 1987-09-17 1988-09-16 Method of binding or separating molecules containing at least one piece of natural or synthetic DNA
PCT/FR1988/000461 WO1989002436A1 (en) 1987-09-17 1988-09-16 Method for fixing and separating molecules comprising at least one natural or synthetic dna fragment
EP19880908250 EP0333813A1 (en) 1987-09-17 1988-09-16 Method for fixing and separating molecules comprising at least one natural or synthetic dna fragment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713010A FR2620706A1 (en) 1987-09-17 1987-09-17 Process for solvent treatment of DNA in a heterogeneous phase

Publications (1)

Publication Number Publication Date
FR2620706A1 true FR2620706A1 (en) 1989-03-24

Family

ID=9355071

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8713010A Withdrawn FR2620706A1 (en) 1987-09-17 1987-09-17 Process for solvent treatment of DNA in a heterogeneous phase

Country Status (1)

Country Link
FR (1) FR2620706A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227744A (en) * 1983-06-08 1984-12-21 Rikaken Kk Granular and powdery glass for recovering dna

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227744A (en) * 1983-06-08 1984-12-21 Rikaken Kk Granular and powdery glass for recovering dna

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 102, 1985, pages 321, no. 200711u, Columbus, Ohio, US; & JP-A-59 227 744 (RIKAKEN K.K.) 21-12-1984 *
CHEMICAL ABSTRACTS, vol. 103, 1985, page 284, no. 50762r, Columbus, Ohio, US; B.MARUO et al.: "Alkaline extraction-glas powder treatment method for isolation and purification of plasmid DNA" & NIHON DAIGAKU NO-JUIGAKUBU GAKUJUTSU KENKYU HOKOKU 1985, (42), 57-61 *
CHEMICAL ABSTRACTS, vol. 96, 1982, page 375, no. 177435d, Columbus, Ohio, US; M.A.MARKO et al.: "A procedure for the large-scale isolation of highly purified plasmid DNA using alkaline extraction and binding to glass powder" & ANAL. BIOCHEM. 1982, 121(2), 382-7 *

Similar Documents

Publication Publication Date Title
Schelhaas et al. Protecting group strategies in organic synthesis
US4997927A (en) Improved process for the purfication of synthetic oligonucleotides
FR2538394A1 (en) PROCESS FOR THE PURIFICATION OF ANTHRACYCLINONIC GLYCOSIDES BY SELECTIVE ADSORPTION ON RESINS
LU81881A1 (en) PROCESS FOR THE PREPARATION OF A SELECTIVELY PROTECTED N-ACYL DERIVATIVE OF AN AMINOGLYCOSIDE ANTIBIOTIC
US20050282226A1 (en) Aptamer capable of specifically adsorbing to bisphenol a and method for obtaining the aptamer
FR2620706A1 (en) Process for solvent treatment of DNA in a heterogeneous phase
CN115867670A (en) Base-modified nucleotides as substrates for TDT-based enzyme nucleic acids
CA2295956C (en) Photonitrosation of cyclododecane in chloroform in quasi-anhydrous medium
EP0487818B1 (en) Process for separating isomers of disubstituted benzenes
JPH0720982B2 (en) Improved purification method for growth hormone-like substances
EP0333813A1 (en) Method for fixing and separating molecules comprising at least one natural or synthetic dna fragment
FR2591505A1 (en) PROCESS FOR EXTRACTING ORGANIC COMPOUNDS FROM THEIR AQUEOUS SOLUTIONS OR SUSPENSIONS
CN1067373C (en) Preparation of nitro phenol
Tanimura et al. Further development of oligoribonucleotide: bis (tributyltin) oxide as a reagent for removal of the internucleotidic phenylthio group via the phosphotriester approach
EP0209470B1 (en) Process for separating by precipitation molybdenum contained in sulfuric or nitric solutions of uranium
FR2760015A1 (en) New industrial process for making diosmine from hesperidine
FR2656150A1 (en) PROCESS FOR RECOVERING USING A PLUTONIUM CROWN ETHER PRESENT IN SOLUTIONS SUCH AS AQUEOUS EFFLUENTS, CONCENTRATED FISSION PRODUCT SOLUTIONS AND CONCENTRATED PLUTONIUM SOLUTIONS
FR2654439A1 (en) METHOD OF RECOVERING GALLIUM FROM BASIC SOLUTIONS CONTAINING SAME.
US20230014428A1 (en) Synthesis of reversible nucleotide terminators by in-situ thio-alkyl group transfer for use in dna sequencing by synthesis
FR2471417A1 (en) PROCESS FOR REMOVING MOLYBDENE FROM URANIUM SOLUTIONS
EP0262010A1 (en) Process for the stereo-specific esterification of an amino acid mixture by reaction of the mixture in the esterification alcohol in the presence of papain
KR860001107A (en) Method for preparing 6- or 11-substituted apovincamic acid derivatives
FR2617829A1 (en) PROCESS FOR SEPARATING RARE EARTHS BY LIQUID-LIQUID EXTRACTION USING HALOGENIC DILUENTS OR CARBOXYLIC ACID TYPE
EP0897907A1 (en) Process for the recovery of nitric acid in a mixture of aromatic dinitro compounds
JP2997981B2 (en) Method for producing 5-amino-4-oxo-2-pentenoic acid having protected amino group

Legal Events

Date Code Title Description
ST Notification of lapse